Given that we have shown that the HLA-B*35 allele could be a potential risk factor for developing sacroiliitis as well as for peripheral arthritis in patients with un-axSpA, we believe that the presence of the HLA-B*35 allele justifies a complete rheumatological assessment just like patients with differentiated forms of the disease. This evidence concerns the gene HLA-B and Sacroiliac arthritis.